Pulmonary artery banding: still a valuable option in developing countries?

Andre Brooks1, Agneta Geldenhuys, Liesl Zuhlke

  • 1Christiaan Barnard Division of Cardiothoracic Surgery, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa. andre.brooks@uct.ac.za

Insights

Pulmonary artery banding (PAB) to defer high-risk biventricular repair in developing countries is ineffective due to poor compliance and high mortality. Early definitive repair is recommended even for high-risk patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Surgery
  • Global Health

Background:

  • Pulmonary artery banding (PAB) is used to defer high-risk biventricular repair in pediatric patients.
  • Socio-economic factors in developing countries may impact the efficacy of staged surgical approaches.

Purpose of the Study:

  • To evaluate the effectiveness of PAB in deferring biventricular repair for high-risk patients in a developing country.
  • To assess outcomes including mortality, re-admission, growth, and definitive repair rates.

Main Methods:

  • Retrospective cohort analysis of 143 consecutive patients undergoing PAB between 2002 and 2007.
  • Patients were considered high-risk for immediate biventricular repair.
  • Follow-up data collected until January 2010, with a minimum of 2 years post-PAB.

Main Results:

  • Total mortality was 29% (42/143), with 21% inter-stage mortality.
  • 50% of patients did not show positive growth post-banding.
  • Only 43% (62/143) achieved definitive biventricular repair; 57% remained uncorrected.

Conclusions:

  • PAB as a strategy to defer biventricular repair is largely ineffective in developing countries, primarily due to poor patient compliance.
  • High inter-stage mortality and unreliable follow-up compromise the benefits of this approach.
  • Early definitive biventricular repair should be considered even for high-risk pediatric patients.
Abstract

Related Concept Videos